Glenview Trust’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,980
Closed -$250K 447
2022
Q4
$250K Buy
12,980
+100
+0.8% +$1.96K 0.01% 393
2022
Q3
$269K Hold
12,880
0.01% 362
2022
Q2
$359K Hold
12,880
0.01% 332
2022
Q1
$404K Hold
12,880
0.01% 330
2021
Q4
$430K Hold
12,880
0.01% 316
2021
Q3
$382K Hold
12,880
0.01% 307
2021
Q2
$344K Hold
12,880
0.01% 331
2021
Q1
$355K Hold
12,880
0.02% 312
2020
Q4
$355K Hold
12,880
0.02% 277
2020
Q3
$335K Hold
12,880
0.02% 265
2020
Q2
$342K Hold
12,880
0.02% 263
2020
Q1
$313K Hold
12,880
0.02% 258
2019
Q4
$390K Hold
12,880
0.02% 264
2019
Q3
$378K Hold
12,880
0.02% 264
2019
Q2
$353K Hold
12,880
0.02% 270
2019
Q1
$368K Hold
12,880
0.02% 261
2018
Q4
$326K Hold
12,880
0.02% 265
2018
Q3
$344K Hold
12,880
0.02% 269
2018
Q2
$347K Hold
12,880
0.03% 244
2018
Q1
$341K Sell
12,880
-2,260
-15% -$60.2K 0.02% 271
2017
Q4
$455K Hold
15,140
0.03% 252
2017
Q3
$451K Hold
15,140
0.03% 242
2017
Q2
$471K Hold
15,140
0.04% 226
2017
Q1
$476K Hold
15,140
0.04% 227
2016
Q4
$441K Buy
+15,140
New +$445K 0.04% 229

Other funds holding HR

Glenview Trust's HR Position: Q1 2023 in Review

Glenview Trust sold out of Healthcare Realty (HR) in Q1 2023, closing a stake of 12,980 shares — an estimated $250K sold.

Glenview Trust first reported a position in HR in Q4 2016 and held it in 25 quarters. The position peaked at $476K in Q1 2017. 418 funds tracked by Wall St. Rank hold HR as of Q1 2023.

  • Glenview Trust reported no remaining Healthcare Realty position as of Q1 2023 after selling out during the quarter.
  • Glenview Trust sold 12,980 Healthcare Realty shares in Q1 2023, an estimated $250K.
  • Glenview Trust first reported a position in Healthcare Realty in Q4 2016 and held it in 25 quarters.
  • Glenview Trust's Healthcare Realty position peaked at $476K in Q1 2017.
  • 418 funds tracked by Wall St. Rank held Healthcare Realty as of Q1 2023.

Based on Glenview Trust's 13F filing for Q1 2023, filed 9 May 2023.